PubMed ID: 19001228 Author(s): Levin LA, Danesh-Meyer HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008 Nov;126(11):1582-5. doi: 10.1001/archopht.126.11.1582. PMID 19001228 Journal: Archives Of Ophthalmology (Chicago, Ill. : 1960), Volume …
Molecular dynamic simulations of nanomechanic chaperone peptide and effects of in silico His mutations on nanostructured function.
PubMed ID: 18683277 Author(s): Barzegar A, Moosavi-Movahedi AA, Mahnam K, Bahrami H, Sheibani N. Molecular dynamic simulations of nanomechanic chaperone peptide and effects of in silico His mutations on nanostructured function. J Pept Sci. 2008 …
Diabetic macular edema: what is focal and what is diffuse?
PubMed ID: 18774122 Author(s): Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU; Diabetic Retinopathy Clinical Research Network. Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol. 2008 Nov;146(5):649-55, 655.e1-6. …
Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study.
PubMed ID: 19001224 Author(s): Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 2008 Nov;126(11):1554-60. doi: …
Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters.
PubMed ID: 18831064 Author(s): Schneider A, Bardakjian TM, Zhou J, Hughes N, Keep R, Dorsainville D, Kherani F, Katowitz J, Schimmenti LA, Hummel M, Fitzpatrick DR, Young TL. Familial recurrence of SOX2 anophthalmia syndrome: phenotypically …
A severity scale for diabetic macular edema developed from ETDRS data.
PubMed ID: 18539929 Author(s): Gangnon RE, Davis MD, Hubbard LD, Aiello LM, Chew EY, Ferris FL 3rd, Fisher MR; Early Treatment Diabetic Retinopathy Study Research Group. A severity scale for diabetic macular edema developed from …
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.
PubMed ID: 19068374 Author(s): Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008 …
The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study.
PubMed ID: 18672224 Author(s): Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008 Nov;146(5):692-9. doi: 10.1016/j.ajo.2008.05.050. Epub 2008 Jul …
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
PubMed ID: 18823656 Author(s): Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) …